ArticleJournal of radiation research2025

Release of HMGB1 from human-derived cancer and normal cells by internal targeted radiotherapy with 131I-meta-iodobenzylguanidine.

Kakeru Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.